Talphera (TLPH) Total Liabilities (2010 - 2026)
Talphera's (TLPH) quarterly Total Liabilities came in at $11.7 million in Q1 2026, up 24.28% year-on-year from $9.4 million in Q1 2025, and down 7.94% quarter-over-quarter from $12.7 million in Q4 2025.
Talphera (TLPH) Total Liabilities (2010 - 2026) Analysis & Trends
Talphera's Total Liabilities history runs 17 years deep, the most recent figure standing at $11.7 million for Q1 2026.
- On a quarterly basis, Total Liabilities rose 24.28% year-over-year to $11.7 million in Q1 2026; TTM through Mar 2026 was $11.7 million, a 24.28% increase from a year earlier, with the FY2025 full-year figure at $12.7 million, up 23.93% from the prior year.
- Total Liabilities slipped to $11.7 million in Q1 2026 per TLPH's latest filing, from $12.7 million in the prior quarter.
- Across five years, Total Liabilities topped out at $110.2 million in Q1 2022 and bottomed at $5.0 million in Q3 2023.
- The 5-year median for Total Liabilities is $11.7 million (2026), against an average of $18.3 million.
- Across the five-year window, Total Liabilities tumbled 89.07% in 2023 and surged 129.57% in 2024, its largest moves.
- Year by year, Total Liabilities stood at $25.7 million in 2022, then plunged by 75.5% to $6.3 million in 2023, then soared by 62.72% to $10.2 million in 2024, then rose by 23.93% to $12.7 million in 2025, then slipped by 7.94% to $11.7 million in 2026.
- Per Business Quant, the three latest TLPH Total Liabilities figures stand at $11.7 million (Q1 2026), $12.7 million (Q4 2025), and $11.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.68 Mn |
| Dec 31, 2025 | 12.68 Mn |
| Sep 30, 2025 | 11.57 Mn |
| Jun 30, 2025 | 9.89 Mn |
| Mar 31, 2025 | 9.40 Mn |
| Dec 31, 2024 | 10.24 Mn |
| Sep 30, 2024 | 11.37 Mn |
| Jun 30, 2024 | 12.13 Mn |
| Mar 31, 2024 | 12.44 Mn |
| Dec 31, 2023 | 6.29 Mn |
| Sep 30, 2023 | 4.95 Mn |
| Jun 30, 2023 | 7.31 Mn |
| Mar 31, 2023 | 12.05 Mn |
| Dec 31, 2022 | 25.67 Mn |
| Sep 30, 2022 | 20.77 Mn |
| Jun 30, 2022 | 22.99 Mn |
| Mar 31, 2022 | 110.24 Mn |
| Dec 31, 2021 | 113.79 Mn |
| Sep 30, 2021 | 115.28 Mn |
| Jun 30, 2021 | 115.58 Mn |